Worldwide Clinical Trials

The trials here

What the 8 trials at this site are about, from their registry records.

Conditions

• Alzheimer disease2 trials
• Gout2 trials
• Multiple sclerosis2 trials
• Cerebral palsy1 trial
• Dystonia1 trial
• Obesity1 trial
• Sickle cell disease1 trial
• Spinal cord injury1 trial
• Stroke1 trial

Phase

• Phase 16 trials
• Phase 21 trial
• Phase 2/31 trial

Status

• Completed4 trials
• Terminated2 trials
• Active, not recruiting1 trial
• Withdrawn1 trial

Lead sponsor

• Atom Therapeutics Co., Ltd2 trials
• Acta Pharmaceuticals1 trial
• Acumen Pharmaceuticals1 trial
• Contineum Therapeutics1 trial
• Fulcrum Therapeutics1 trial
• and 2 more

Running trials

• Active, not recruiting

  A Study of PF-08653945 and PF-08653944 in Adults With Overweight or Obesity

  NCT07575932· Phase 2· Pfizer· Source

Closed trials

• Terminated

  Single-dose Pharmacokinetics of Pociredir in Participants With Sickle Cell Disease

  NCT07431398· Phase 1· Fulcrum Therapeutics· Source

• Withdrawn

  A Clinical Trial to Study Single- and Multiple- Doses of GSM-779690T in Healthy Participants

  NCT07155980· Phase 1· Acta Pharmaceuticals· Source

• Completed

  A Study Comparing the Safety, Tolerability, and Pharmacokinetics of Sabirnetug IV and Sabirnetug + rHuPH20 SC in Healthy Participants

  NCT06511570· Phase 1· Acumen Pharmaceuticals· Source

• Terminated

  Extension Study of ABP-671 in Participants With Gout

  NCT06276556· Phase 2/3· Atom Therapeutics Co., Ltd· Source

• Completed

  A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Oral ABP-745 Administration in Healthy Volunteers

  NCT06258213· Phase 1· Atom Therapeutics Co., Ltd· Source

• Completed

  Single and Multiple Ascending Dose Study of MTR-601 in Healthy Individuals

  NCT06117020· Phase 1· Motric Bio· Source

• Completed

  Study Evaluating Safety and Tolerability of Escalating Single and Multiple Doses of PIPE-791 and Food Effect in Healthy Volunteers

  NCT05983939· Phase 1· Contineum Therapeutics· Source